Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Genmab a::S symbols : Bmy save search
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
| Email alert
Add to watchlist
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
| Email alert
Add to watchlist
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | News | $290.34 3.83% 340
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Published: 2023-03-29 (Crawled : 22:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 1.48%
H: 0.0%
C: 0.0%
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: 0.0%
H: 1.69%
C: 1.42%
BOLT | $1.19 7.21% 6.72% 150K
|
|
| O: 5.43%
H: 0.74%
C: -1.47%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.29%
H: 0.22%
C: -0.26%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: 0.37%
H: 0.05%
C: -0.4%
business year update financial results
Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
Published: 2022-11-04 (Crawled : 18:00) - prnewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: -2.57%
H: 3.43%
C: 2.04%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 2.28%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.13%
H: 0.63%
C: 0.53%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.25%
H: 0.03%
C: -0.78%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.97%
H: 0.18%
C: -2.13%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.42%
H: 0.59%
C: -0.04%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.64%
H: 0.16%
C: -0.05%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: 0.58%
H: 0.93%
C: 0.93%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -1.48%
H: 2.81%
C: 2.71%
report cancer market
Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-10 (Crawled : 23:00) - biospace.com/
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: -0.39%
H: 5.07%
C: -0.05%
BOLT | $1.19 7.21% 6.72% 150K
|
|
| O: 3.07%
H: 8.51%
C: 7.23%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.32%
H: 0.16%
C: -0.45%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: 2.33%
H: 0.64%
C: -0.72%
update results
Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others
Published: 2022-04-28 (Crawled : 21:00) - prnewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: 2.93%
H: 1.47%
C: 1.33%
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: -0.99%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.19%
H: 0.59%
C: -1.36%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -3.61%
H: 3.02%
C: 2.02%
BHC | $8.56 0.35% 0.0% 2M
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: 1.4%
H: 0.82%
C: -1.07%
t-cell
Hematological Malignancies Drugs Market worth $ 42.78 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-08 (Crawled : 11:00) - prnewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: -0.14%
H: 5.36%
C: 5.36%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -2.75%
H: 0.28%
C: -1.04%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.38%
H: 1.81%
C: 0.28%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -1.55%
H: 0.71%
C: -0.28%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 1.4%
H: 0.7%
C: -1.15%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: -0.3%
H: 3.38%
C: 0.32%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
ema drug report
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.